Suzhou Basecare Medical Corporation Limited 2170.HK Stock
Suzhou Basecare Medical Corporation Limited Price Chart
Suzhou Basecare Medical Corporation Limited 2170.HK Financial and Trading Overview
Contents
- Suzhou Basecare Medical Corporation Limited Price Chart
- Suzhou Basecare Medical Corporation Limited 2170.HK Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Suzhou Basecare Medical Corporation Limited
- Q&A For Suzhou Basecare Medical Corporation Limited Stock
Suzhou Basecare Medical Corporation Limited stock price | 2 HKD |
Previous Close | 3.51 HKD |
Open | 3.7 HKD |
Bid | 3.57 HKD x N/A |
Ask | 3.7 HKD x N/A |
Day's Range | 3.53 - 3.9 HKD |
52 Week Range | 2.54 - 6.36 HKD |
Volume | 174.5K HKD |
Avg. Volume | 100.67K HKD |
Market Cap | 976.49M HKD |
Beta (5Y Monthly) | 0.697994 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.76 HKD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.27 HKD |
2170.HK Valuation Measures
Enterprise Value | -299068736 HKD |
Trailing P/E | N/A |
Forward P/E | -11.9 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 6.930312 |
Price/Book (mrq) | 0.61308604 |
Enterprise Value/Revenue | -2.123 |
Enterprise Value/EBITDA | 1.42 |
Trading Information
Suzhou Basecare Medical Corporation Limited Stock Price History
Beta (5Y Monthly) | 0.697994 |
52-Week Change | -29.79% |
S&P500 52-Week Change | 20.43% |
52 Week High | 6.36 HKD |
52 Week Low | 2.54 HKD |
50-Day Moving Average | 4.19 HKD |
200-Day Moving Average | 4.1 HKD |
2170.HK Share Statistics
Avg. Volume (3 month) | 100.67K HKD |
Avg. Daily Volume (10-Days) | 108K HKD |
Shares Outstanding | 82.71M |
Float | 82.71M |
Short Ratio | N/A |
% Held by Insiders | 5.62% |
% Held by Institutions | 22.68% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -87.057% |
Operating Margin (ttm) | -153.32% |
Gross Margin | 42.24% |
EBITDA Margin | -149.46% |
Management Effectiveness
Return on Assets (ttm) | -7.54% |
Return on Equity (ttm) | -8.022% |
Income Statement
Revenue (ttm) | 140.9M HKD |
Revenue Per Share (ttm) | 0.52 HKD |
Quarterly Revenue Growth (yoy) | 26.60% |
Gross Profit (ttm) | N/A |
EBITDA | -210592000 HKD |
Net Income Avi to Common (ttm) | -131784000 HKD |
Diluted EPS (ttm) | -0.56 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1.33B HKD |
Total Cash Per Share (mrq) | 4.88 HKD |
Total Debt (mrq) | 75.54M HKD |
Total Debt/Equity (mrq) | 4.75 HKD |
Current Ratio (mrq) | 13.335 |
Book Value Per Share (mrq) | 5.823 |
Cash Flow Statement
Operating Cash Flow (ttm) | -188768992 HKD |
Levered Free Cash Flow (ttm) | -195896752 HKD |
Profile of Suzhou Basecare Medical Corporation Limited
Country | Hong Kong |
State | N/A |
City | Suzhou |
Address | Building A3 BioBay |
ZIP | N/A |
Phone | N/A |
Website | https://www.basecare.cn |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 479 |
Suzhou Basecare Medical Corporation Limited, an investment holding company, engages in the research, development, manufacture, and provision of genetic testing solutions for assisted human reproduction and sale of genetic testing devices and instruments in the People's Republic of China. The company offers genetic test kit products, which include pre-implantation genetic test kits, such as PGT-A to detect aneuploidy; PGT-M to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage. It also provides CNV kits, a reagent kit to test abortive tissues for a comprehensive panel of copy number variations for miscarriage. It also offers liquid nitrogen storage dewar, Cryopreservation system, and sperm quality analyzer; and universal kits for sequencing effects, sample preservation solution, nucleic acid purification and DNA extraction kits. The company also engages in the research, development, manufacture, and sale of testing kits, testing devices, and instruments. In addition, it provides marketing services; and engages in the research and development of software for r testing devices and instruments. The company serves hospitals and reproductive clinics. Suzhou Basecare Medical Corporation Limited was incorporated in 2010 and is headquartered in Suzhou, China.
Q&A For Suzhou Basecare Medical Corporation Limited Stock
What is a current 2170.HK stock price?
Suzhou Basecare Medical Corporation Limited 2170.HK stock price today per share is 2 HKD.
How to purchase Suzhou Basecare Medical Corporation Limited stock?
You can buy 2170.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Suzhou Basecare Medical Corporation Limited?
The stock symbol or ticker of Suzhou Basecare Medical Corporation Limited is 2170.HK.
Which industry does the Suzhou Basecare Medical Corporation Limited company belong to?
The Suzhou Basecare Medical Corporation Limited industry is Medical Devices.
How many shares does Suzhou Basecare Medical Corporation Limited have in circulation?
The max supply of Suzhou Basecare Medical Corporation Limited shares is 273.53M.
What is Suzhou Basecare Medical Corporation Limited Price to Earnings Ratio (PE Ratio)?
Suzhou Basecare Medical Corporation Limited PE Ratio is now.
What was Suzhou Basecare Medical Corporation Limited earnings per share over the trailing 12 months (TTM)?
Suzhou Basecare Medical Corporation Limited EPS is -0.76 HKD over the trailing 12 months.
Which sector does the Suzhou Basecare Medical Corporation Limited company belong to?
The Suzhou Basecare Medical Corporation Limited sector is Healthcare.